Cargando…

Sestrin 2 levels are associated with emphysematous phenotype of COPD

Sestrins (Sesns) are a family of highly conserved stress-inducible proteins and various stresses have been shown to strongly up-regulate them. Sestrin 2 (Sesn2) deficiency has been shown to partially suppress pulmonary emphysema. The aim of this study was to evaluate Sesn2 levels in COPD patients an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angelakis, Leonidas, Papaioannou, Andriana I., Papathanasiou, Evgenia, Mazioti, Argiro, Kallieri, Maria, Papatheodorou, George, Patentalakis, George, Hillas, Georgios, Papiris, Spyridon, Koulouris, Nikolaos, Loukides, Stelios, Bakakos, Petros
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426901/ https://www.ncbi.nlm.nih.gov/pubmed/36040980 http://dx.doi.org/10.1371/journal.pone.0273652

Ejemplares similares

Sirtuin 1: Endocan and Sestrin 2 in Different Biological Samples in Patients with Asthma. Does Severity Make the Difference?
por: Tsilogianni, Zoe, et al.
Publicado: (2020)

Sputum interleukin (IL)-13 as a biomarker for the evaluation of asthma control
por: Tsilogianni, Zoi, et al.
Publicado: (2015)

Eosinopenia as a Prognostic Biomarker for Noninvasive Ventilation Use in COPD Exacerbations
por: Bartziokas, Konstantinos, et al.
Publicado: (2023)

Dual Bronchodilator in the Era of Triple Therapy
por: Papaioannou, Andriana I, et al.
Publicado: (2020)

Identification of asthma phenotypes using blood cell count
por: Papaioannou, Andriana I, et al.
Publicado: (2022)

Exhaled breath condensate pH as a biomarker of COPD severity in ex-smokers
por: Papaioannou, Andriana I, et al.
Publicado: (2011)

IL-26 in the Lung and Its Role in COPD Inflammation
por: Bartziokas, Konstantinos, et al.
Publicado: (2022)

An algorithmic approach for the treatment of severe uncontrolled asthma
por: Zervas, Eleftherios, et al.
Publicado: (2018)

Primary care and COVID-19: cutting the Gordian knot – the Greek experience and algorithm
por: Tomos, Ioannis, et al.
Publicado: (2020)

Severe asthma: anti-IgE or anti-IL-5?
por: Papathanassiou, Evgenia, et al.
Publicado: (2016)

Cardiovascular Diseases in COPD: From Diagnosis and Prevalence to Therapy
por: Papaporfyriou, Anastasia, et al.
Publicado: (2023)

Greek Guidelines for the Management of COPD, a Proposal of a Holistic Approach Based on the needs of the Greek Community
por: Tzanakis, Nikolaos, et al.
Publicado: (2022)

Exploring Mechanisms in COPD: Time for Biomarker Reappraisal?
por: Voulgareli, Ilektra, et al.
Publicado: (2023)

Depression Levels Influence the Rate of Asthma Exacerbations in Females
por: Anastasia, Papaporfyriou, et al.
Publicado: (2021)

Severe Eosinophilic Asthma
por: Bakakos, Agamemnon, et al.
Publicado: (2019)

Direct and Indirect Costs of Asthma Management in Greece: An Expert Panel Approach
por: Souliotis, Kyriakos, et al.
Publicado: (2017)

Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE)
por: Papaioannou, Andriana I., et al.
Publicado: (2016)

Pulmonary hemorrhage in patients receiving anti-platelets- a case series and a suggested therapeutic algorithm
por: Tomos, Ioannis, et al.
Publicado: (2022)

Severe Asthma in the Era of Biologics: Continuous Challenges
por: Schoini, Pinelopi, et al.
Publicado: (2023)

Implication of IL-18 in chronic inflammation of severe refractory asthma
por: Rovina, Nikoletta, et al.
Publicado: (2015)

Revisiting IL-13 blockade: can we reach the wonderland the inhaled way?
por: Papaioannou, Andriana I., et al.
Publicado: (2018)

Patient-Reported Outcome Measurements in Patients with COPD-Obstructive Sleep Apnea Overlap Syndrome: Time for Action?
por: Papaioannou, Andriana I, et al.
Publicado: (2022)

Epidemiology and Immunopathogenesis of Virus Associated Asthma Exacerbations
por: Bakakos, Agamemnon, et al.
Publicado: (2023)

SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics
por: Papaioannou, Andriana I., et al.
Publicado: (2022)

Increased Red Cell Distribution Width Is Associated With Disease Severity in Hospitalized Adults With SARS-CoV-2 Infection: An Observational Multicentric Study
por: Karampitsakos, Theodoros, et al.
Publicado: (2020)

Asthma-COPD Overlap Syndrome: Recent Insights and Unanswered Questions
por: Fouka, Evangelia, et al.
Publicado: (2022)

Paucigranulocytic Asthma: Potential Pathogenetic Mechanisms, Clinical Features and Therapeutic Management
por: Papaioannou, Andriana I., et al.
Publicado: (2022)

Decreased Serum Sirtuin-1 in COPD
por: Yanagisawa, Satoru, et al.
Publicado: (2017)

Patients Hospitalized for COVID-19 in the Periods of Delta and Omicron Variant Dominance in Greece: Determinants of Severity and Mortality
por: Karageorgou, Vagia, et al.
Publicado: (2023)

The disparity of health facilities in an urban area discourages proposed treatment application in inoperable lung cancer patients
por: Hillas, Georgios, et al.
Publicado: (2010)

Reducing Tolerance for SABA and OCS towards the Extreme Ends of Asthma Severity
por: Bakakos, Petros, et al.
Publicado: (2022)

New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis
por: Striz, Ilja, et al.
Publicado: (2023)

Fever and multilobular mass of the right lung in a young adult with asthma
por: Sotiriou, Adamantia, et al.
Publicado: (2015)

Simultaneous Diagnosis of Emphysematous Osteomyelitis and Emphysematous Pyelonephritis in a Diabetic Patient
por: Tatakis, Fotios-Panagiotis, et al.
Publicado: (2019)

Spirometric Values of Greek People and Comparison with ECSC and GLI Values in COPD People
por: Tatsis, Nikolaos, et al.
Publicado: (2018)

Modified SCOPE (mSCOPE) Score as a Tool to Predict Mortality in COVID-19 Critically Ill Patients
por: Zanelli, Stavroula, et al.
Publicado: (2023)

On the Minute Anatomy of the Emphysematous Lung
por: Rainey, George
Publicado: (1850)

C-Reactive Protein as a Predictor of Survival and Length of Hospital Stay in Community-Acquired Pneumonia
por: Travlos, Apostolos, et al.
Publicado: (2022)

Control of asthma in real life: still a valuable goal?
por: Papaioannou, Andriana I., et al.
Publicado: (2015)

Physiological predictors Of peak inspiRatory flow using Observed lung function resultS (POROS): evaluation at discharge among patients hospitalized for a COPD exacerbation
por: Price, David B, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1h6gg7t26ona4u61d6djk1hdv6